focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.76
Ask: 10.22
Change: -0.01 (-0.10%)
Spread: 0.46 (4.713%)
Open: 9.76
High: 9.77
Low: 9.75
Prev. Close: 9.76
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2021 MREL Requirement

1 Jun 2021 07:00

RNS Number : 3047A
Banco Bilbao Vizcaya Argentaria SA
01 June 2021
 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, hereby communicates the following:

INSIDE INFORMATION

BBVA has received a new communication from the Bank of Spain regarding its minimum requirement for own funds and eligible liabilities ("MREL"), as determined by the Single Resolution Board ("SRB"), that has been calculated taking into account the financial and supervisory information as of December 31, 2019[1], and which supersedes the previous MREL communication published on November 19, 2019.

In accordance with this new MREL communication, BBVA has to reach, by January 1, 2022, an amount of own funds and eligible liabilities equal to 24.78%[2] of the total risk weighted assets ("RWAs") of its resolution group, on sub-consolidated level[3] (the "MREL in RWAs"). Within this MREL in RWAs, an amount equal to 13.50%2 of the RWAs shall be met with subordinated instruments (the "subordination requirement in RWA").

This MREL in RWA is equal to 10.25% in terms of the total exposure considered for calculating the leverage ratio (the "MREL in LR"), while the subordination requirement in RWAs is equal to 5.84% in terms of the total exposure considered for calculating the leverage ratio (the "subordination requirement in LR").

The current own funds and eligible liabilities structure of the resolution group meets the MREL in RWAs, the MREL in LR, the subordination requirement in RWAs and the subordination requirement in LR.

 

MREL

 

% RWAs

% Leverage ratio (LR) exposure

Requirement as of January 1, 2022

24.78%

10.25%

Own funds and eligible liabilities as of March 31, 2021

29.23%[4]

13.40%

 

Subordination requirement

 

% RWAs

% Leverage ratio (LR) exposure

Requirement as of January 1, 2022

13.50%

5.84%

Own funds and eligible subordinated liabilities as of March 31, 2021

25.95%4

11.89%

 

 

Madrid, May 31, 2021

 

[1] As the reference date used for the calibration of the MREL has been December 31, 2019, the effects, among other issues, of the expected sale of the BBVA Group subsidiary BBVA USA Bancshares, Inc, which was announced to the market on November 16, 2020, have not been taken into account.

[2] In accordance with the new applicable regulation, the MREL in RWAs and the subordination requirement in RWAs do not include the combined capital buffer requirement. For these purposes, the applicable combined capital buffer requirement would be 2.5%, without prejudice to any other buffer that may be applicable at any time.

[3] Pursuant to BBVA Group's MPE (Multiple Point of Entry) resolution strategy, as established by the SRB, the resolution group consists of Banco Bilbao Vizcaya Argentaria S.A. and the subsidiaries that belong to the same European resolution group. As of December 31, 2019, the RWAs of the resolution group amounted to 204,218 million euros and the total exposure considered for calculating the leverage ratio amounted to 422,376 million euros.

[4] Own funds and eligible liabilities to meet both MREL in RWAs or subordination requirement in RWAs, as applicable, and the combined capital buffer requirement, which would be 2.5%, without prejudice to any other buffer that may apply at any time.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAUKRAWUVOAR
Date   Source Headline
4th Nov 201612:18 pmRNSDividend Option
27th Oct 20167:00 amRNS3rd Quarter Results Presentation
27th Oct 20167:00 amRNS3rd Quarter Results Information
27th Oct 20167:00 amRNS3rd Quarter Results
24th Oct 20165:02 pmRNSHR 3Q16 Results presentation announcement
20th Oct 20167:00 amRNSEnding trading period Divend Option October 2016
29th Sep 20167:00 amRNSDividend Option Information October 2016
16th Sep 20161:43 pmRNSDividend Option Calendar October 2016
9th Sep 20165:26 pmRNSRegistration of the merger by absorption of CX
1st Sep 20165:34 pmRNSMerger by absorption of Catalunya Banc by BBVA
4th Aug 20168:42 amRNSSupplemental to the Offering Circular
1st Aug 20167:00 amRNSStress Test EBA
29th Jul 20167:09 amRNSInformation of Results 2Q2016
29th Jul 20167:02 amRNS2nd Quarter 2016 Results Presentation
29th Jul 20167:00 amRNS2nd Quarter Results Press Release
28th Jul 20166:03 pmRNSNEW AUDITOR SELECTION
28th Jul 20167:00 amRNSNew Organizational Structure
22nd Jul 20165:33 pmRNS2Q16 Results presentation announcement
24th Jun 20164:38 pmRNSPrice Monitoring Extension
23rd Jun 20167:00 amRNSDividend July 2016
9th May 20168:39 amRNSSupplemental to the Offering Circular
6th May 20169:59 amRNSBBVA Scrip Dividend
29th Apr 201612:45 pmRNS2015 Audited Financial Statements
28th Apr 20168:21 amRNSAmendment Results Presentation 1Q2016
28th Apr 20167:29 amRNSResults Presentation 1Q2016
28th Apr 20167:22 amRNSPress Release 1st Quarter Results 2016
28th Apr 20167:21 amRNS1st Quarter Results 2016
25th Apr 20165:02 pmRNSPresentation of results announcement 1Q2016
20th Apr 20167:00 amRNSOptional Dividend Result
8th Apr 20167:00 amRNSPreferred Securities
1st Apr 20167:00 amRNSOptional dividend
1st Apr 20167:00 amRNSModification about composition of committees
1st Apr 20167:00 amRNSIntegration process of BBVA Group
14th Mar 20167:00 amRNSIRS Pilar III Basilea
11th Mar 20162:52 pmRNSOptional dividend calendar
11th Mar 20162:51 pmRNSGeneral Meeting Agreements
11th Mar 20167:51 amRNSDBRS rating actions
24th Feb 20164:28 pmRNSHOME MEMBER STATE DISCLOSURE
10th Feb 20164:02 pmRNSSupplemental to the Offering Circular
10th Feb 201612:02 pmRNSBBVA's Annual Report 2015 (Spanish version)
10th Feb 201612:00 pmRNSBBVA's Annual Report 2015
8th Feb 20167:00 amRNSAnnual corporate governance report
5th Feb 20165:26 pmRNSIAR 2015
5th Feb 20168:38 amRNSAGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS
3rd Feb 20169:28 amRNSAnnual General Meeting 2016 Call
3rd Feb 20167:40 amRNS20160203 Folleto_eng
3rd Feb 20167:38 amRNS20160203 Results Presentation
3rd Feb 20167:17 amRNSPress Release 4Q15
29th Jan 20167:59 amRNS4Q15 Results presentation announcement
20th Jan 20168:30 amRNSPost-Stabilisation Notice - BBVA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.